KPMG Consulting Releases Japanese Version of 'Intelligent Life Sciences – A Blueprint for Value Creation Through AI-Driven Transformation'
KPMG Consulting has released the Japanese version of a report surveying AI usage in the life sciences sector. While 97% of organizations have achieved operational improvements through AI, the report indicates that transforming organizational structure and data infrastructure is essential for maximizing ROI.
📋 Article Processing Timeline
- 📰 Published: May 21, 2026 at 20:00
- 🔍 Collected: May 21, 2026 at 11:31
- 🤖 AI Analyzed: May 21, 2026 at 11:46 (14 min after Collected)
KPMG Consulting has released the Japanese version of the report, 'Intelligent life sciences – A blueprint for value creation through AI-driven transformation,' which outlines the challenges and approaches for life sciences organizations to create long-term value through AI.
This report is based on a survey conducted by KPMG International covering 1,390 managers in major global markets, including 183 senior AI leaders driving business transformation through AI in the life sciences sector.
Key survey findings include:
1. AI is a critical differentiator: 86% believe that organizations fully adopting AI enhance their competitive advantage.
2. The role of AI is clear: 92% understand the AI technologies and capabilities they should invest in.
3. Operational improvement via AI: 97% have achieved operational improvements, with 73% achieving efficiency gains.
4. High ROI achievement is limited: Currently, only 31% of organizations are achieving high ROI.
5. Adaptable organizational structure: Organizations combining departmental and agile models are twice as likely to achieve high ROI.
6. Data as a barrier: 68% cite data challenges as one of the biggest barriers to AI adoption.
7. The future of agentic AI: 89% allow AI to make end-to-end autonomous decisions for specific processes.
To maximize value from AI in the life sciences sector, it is crucial to formulate AI strategies and build scalable foundations for technology and data.
This report is based on a survey conducted by KPMG International covering 1,390 managers in major global markets, including 183 senior AI leaders driving business transformation through AI in the life sciences sector.
Key survey findings include:
1. AI is a critical differentiator: 86% believe that organizations fully adopting AI enhance their competitive advantage.
2. The role of AI is clear: 92% understand the AI technologies and capabilities they should invest in.
3. Operational improvement via AI: 97% have achieved operational improvements, with 73% achieving efficiency gains.
4. High ROI achievement is limited: Currently, only 31% of organizations are achieving high ROI.
5. Adaptable organizational structure: Organizations combining departmental and agile models are twice as likely to achieve high ROI.
6. Data as a barrier: 68% cite data challenges as one of the biggest barriers to AI adoption.
7. The future of agentic AI: 89% allow AI to make end-to-end autonomous decisions for specific processes.
To maximize value from AI in the life sciences sector, it is crucial to formulate AI strategies and build scalable foundations for technology and data.
FAQ
Where can I find the KPMG report?
The 'Intelligent life sciences' report is available on the official KPMG Consulting website.
Why do many organizations struggle to achieve high ROI with AI?
Major factors include data silos, inconsistent data quality, and rigid organizational structures, with the adoption of agile models being key to improvements.
Is agentic AI being used in the industry?
Yes, 89% of organizations allow autonomous decision-making, and large-scale adoption is underway.